Center for Scientific Review; Amended Notice of Meeting
---
identifier: "/us/fr/2026-03084"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Center for Scientific Review; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2026-03084"
section_name: "Center for Scientific Review; Amended Notice of Meeting"
positive_law: false
currency: "2026-02-17"
last_updated: "2026-02-17"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2026-03084"
document_type: "notice"
publication_date: "2026-02-17"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "91 FR 7294"
fr_volume: 91
---
# Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Drug and Biologic Therapeutic Delivery Study Section, March 16, 2026, 09:00 a.m. to March 17, 2026, 06:00 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the *Federal Register* on February 11, 2026, 91 FR 6321, FRN Doc. 2026-02669.
The meeting date changed from a 2-day meeting to a 1-day meeting, March 16, 2026. The meeting is closed to the public.
Dated: February 12, 2026.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.